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Abstract 1 
Background and Objective: Epithelial cells derived from different regions exhibit 2 
marked differences in their differentiation capacity, allowing them to provide a suitable 3 
protective barrier. We aimed to clarify the role of peptidylarginine deiminase (PAD) in 4 
modifying the key epidermal proteins filaggrin (FLG) and keratin 1 (K1) during 5 
stratification of the rat palate and buccal mucosa.  6 
Materials and Methods: We performed immunofluorescence, immunoblotting, PAD 7 
activity assays, and two-dimensional electrophoresis, and developed an organotypic 8 
culture model.  9 
Results: PAD1 expression was highest in the palate, whereas PAD2, PAD3, and PAD4 10 
expression was highest in the skin, suggesting the tissue-specific expression of PAD 11 
isozymes that leads to differences in calcium dependency. Immunoblotting showed that 12 
the FLG monomer, as well as its degradation products and precursor (proFLG), were 13 
most abundantly expressed in the skin but had low expression in the palate, whereas 14 
only faint proFLG expression was detected in the buccal mucosa. FLG and K1 were 15 
co-localized with PAD1 and were likely to be citrullinated in the cornified layers of the 16 
skin; this co-localization was not detected on the palatal surface, and dot-like presence 17 
of proFLG that might be citrullinated and that of PAD1 were found in the granules of 18 
the palate. Organotypic models derived from the rat palate revealed that PAD inhibition 19 
reduced the breakdown of FLG, increased its association with K1 together with 20 
epithelial compaction, and decreased permeability in a dye permeability assay. 21 
Conversely, PAD stimulation had the opposite effects.  22 
Conclusions: Citrullination is likely a protein modification that plays an important role 23 
in maintaining the structure and function of oral cornified mucosa in a way that is 24 
distinctly different from that of the skin. 25 
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Introduction 1 
Citrullination or deimination is one of the post-translational modifications of 2 
proteins. In this process, peptidylarginine deiminase (PAD) changes the structure of key 3 
epidermal proteins, such as filaggrin (FLG) and keratins, by converting arginine 4 
residues into neutral citrulline residues in the stratifying epithelium (1). Profilaggrin 5 
(ProFLG) is a large molecule that accumulates in keratohyalin granules. During 6 
cornification of the skin, it is proteolyzed into FLG repeats (monomers) and other 7 
domains (2). FLG monomers bind to keratin intermediate filaments (KIFs), causing 8 
tight aggregation into macrofibrils (3). The tightly packed KIF leads to cellular 9 
compaction aligned parallel to the outer surface of the epidermis, which generates a 10 
barrier against the environment (4). However, loss of positive charge per citrulline 11 
residue induced by PAD changes the intramolecular and intermolecular interactions 12 
with the keratin matrix, making the less ordered FLG structure more susceptible to 13 
proteolytic degradation (1).  14 
The PAD family is composed of five calcium-dependent isozymes. PAD1 has 15 
mainly been detected in the human epidermis and uterus (1), and rat epidermis and 16 
stomach (5). Rat PAD1 cDNA was cloned from a retinoic acid-treated culture of a 17 
newborn keratinocyte cell line (6). PAD1 plays a major role in the citrullination of 18 
keratin 1 (K1) in the epidermis (7, 8). K1 citrullination was shown to be decreased in 19 
the hyperproliferative plaques in psoriasis and bullous congenital ichthyosiform 20 
erythroderma (9, 10). PAD2 is expressed in a variety of rat tissues such as the epidermis, 21 
brain, lung, spleen, stomach, and uterus (5). PAD3 is expressed in the inner root sheath 22 
and medulla of hair follicles where it crosslinks the structural protein trichohyalin (1, 23 
11). PAD4 is found in hematopoetic cells (1). All of these PAD subtypes are reportedly 24 
expressed in the rat epidermis (5). Among them, PAD1 and PAD3 proteins are 25 
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colocalized with FLG, suggesting that they are both involved in FLG citrullination in 1 
the epidermis (8, 11). 2 
Epithelial cells derived from different regions including the oral mucosa exhibit 3 
marked differences in their differentiation capacity, allowing them to provide a suitable 4 
protective barrier (12). Dale et al. (13) demonstrated site and age differences in the 5 
distribution of FLG and its precursor protein in rat oral mucosa; as in the epidermis, the 6 
protein was observed in cornified layers and in keratohyalin granules throughout the 7 
mouth of newborn (0–2 days old) rats, whereas it was mainly present in keratohyalin 8 
granules in adult rats. Our previous immunohistochemical and real-time PCR studies 9 
showed that the relative levels of FLG differed among the palate, buccal mucosa, 10 
esophagus, and skin in 7-day-old rats (14). FLG is expressed in the human oral mucosa 11 
as well as in the epidermis (15, 16). ProFLG is detectable in human nonkeratinized, 12 
parakeratinized, and orthokeratinized oral epithelium, although FLG monomer is 13 
expressed in only the orthokeratinized palate (15). Expression of FLG proteins in the 14 
human oral mucosa was shown to markedly increase under pathological conditions 15 
involving hyperkeratosis such as lichen planus and leucoplakia (17), which occur 16 
independently of defects in the FLG gene (18). These data suggest that the enzymatic 17 
breakdown of proFLG and the resulting pattern of stratification are likely to be distinct 18 
among stratified tissues such as the skin and oral mucosa. Thus, it is likely that the post-19 
translational modification of proFLG and FLG by PAD influences epithelial 20 
differentiation and cornification of oral mucosa (15). 21 
In this study, we aimed to clarify the role of protein citrullination in the 22 
stratification and cornification of oral mucosa. First, we compared the expression of 23 
FLG, proFLG, and PAD isozymes, and evaluated PAD activity and protein 24 
citrullination in the epithelial cell layers of the skin, palate, and buccal mucosa of 7-25 
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day-old rats. Second, we developed a 3-dimensional (3D) mucosal model derived from 1 
epithelial cells and fibroblasts isolated from the rat palate. Finally, we examined 2 
whether an inhibitor and activator of PAD could alter FLG expression, as well as the 3 
structure and function of the epithelial layers. 4 
 5 
Materials and Methods 6 
Antibodies and reagents  7 
The following primary antibodies were used: mouse monoclonal K1 (NB100-8 
2756; Novus Biologicals, Littleton, CO), β-actin (sc-47778; Santa Cruz Biotechnology, 9 
Santa Cruz, CA), rabbit polyclonal anti-cyclic citrullinated peptide (CCP, bs-1053R; 10 
Bioss Inc., Woburn, MA), anti-PAD1 (NBP2-37761; Novus Biologicals), human anti-11 
modified citrulline (MC, clone C4; EMD Millipore Corp., Temecula, CA), and rabbit 12 
anti-FLG antiserum (generously gifted by Dr. Ishigami, Tokyo Metropolitan Institute 13 
of Gerontology, Tokyo, Japan). Cl-Amidine trifluoroacetate salt was purchased from 14 
Cayman Chemical (Ann Arbor, MI) and theophylline-7-acetic acid (acefylline) was 15 
purchased from Toronto Research Chemicals, Inc. (North York, Canada). The other 16 
compounds were obtained from Sigma-Aldrich (St. Louis, MO). 17 
 18 
Histological and immunohistochemical examination  19 
Neonatal Wistar rats (7 days old) were anesthetized with isoflulane and sacrificed. 20 
Permission for the procedures was granted by the Animal Research Committee of 21 
Fukuoka Dental College (Fukuoka, Japan). The palate, buccal mucosa, and abdominal 22 
skin were dissected as previously described (14). The in vivo rat tissues or reconstructed 23 
model were fixed in 10% formalin solution, routinely processed, and embedded in 24 
paraffin. Sections 3 µm thick were stained with hematoxylin and eosin (H&E). To 25 
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obtain frozen sections 10 µm thick, the samples were fixed briefly in 4% 1 
paraformaldehyde (PFA) solution, gradually dehydrated with 10%, 15%, and 20% 2 
sucrose solution, and embedded in Super Cryoembedding Medium (Section-Lab Co., 3 
Hiroshima, Japan). To detect MC immunoreactivity in the tissue sections, citrulline 4 
residues on the sections were chemically modified with 2,3-butanedione monoxime and 5 
antipyrine under acidic conditions (19) prior to applying the antibodies. For 6 
immunofluorescence double staining, the tissue sections with or without chemical 7 
modification were blocked in 10% normal goat serum and then incubated with a 8 
combination of two antibodies listed below for 2 h; anti-FLG serum (1:40,000), anti-9 
MC (1:100), CCP (1:200), PAD1 (1:100), and K1 (1:100) antibodies, followed by a 1 h 10 
incubation at room temperature with goat anti-rabbit, anti-mouse, or anti-human 11 
immunoglobulin G (IgG) antibodies conjugated with Alexa 488 or Alexa 594 (1:800). 12 
The sections were counterstained with DAPI (ProLong Gold; Thermo Fisher Scientific, 13 
Waltham, MA). Fluorescence was observed using a fluorescence microscope (BZ-14 
9000; Keyence, Osaka, Japan) and a confocal laser scanning microscope (LSM710; 15 
Carl Zeiss MicroImaging GmbH, Gottingen, Germany). Quantification of the relative 16 
area and width of the layers in the images and calculation of Pearson’s colocalization 17 
coefficient were performed with ImageJ software (National Institutes of Health [NIH], 18 
Bethesda, MD). 19 
 20 
Evaluation of mRNA expression levels by real-time PCR  21 
Total RNA was isolated from the rat tissues and the reconstructed model 22 
(NucleoSpin RNA Kit; Macherey-Nagel GmbH & Co. KG, Düren, Germany), after 23 
which the cDNA was reverse transcribed (PrimeScript RT Reagent Kit; Takara Bio Inc., 24 
Tokyo, Japan). Quantitative PCR (qPCR) was performed with the Applied Biosystems 25 
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7500 Real-Time PCR System with the thermal cycling conditions recommended by the 1 
manufacturer, and with the SYBRR Green method using a pair of specific primers to 2 
target rat proFLG (Forward: 5′-ATGCTAGATGTGGACCACGATGAC-3′, Reverse: 3 
5′-TGTTCCCTCTTCCTCTTGGGCTT-3′; GenBank accession number: 4 
XM_003753631), rat PAD1 (Forward: 5′-CACAGGCAAGGTGAAGAAAGG-3′, 5 
Reverse: 5′-TGTTTGTAGTTGGAGAGGGAGG-3′; GenBank accession number: 6 
NM_019332.1), rat PAD2 (Forward: 5′-TCCTGAAAGAGGTGAAGAACCTG-3′, 7 
Reverse: 5′-TACTGGGAAGCCTTTGTGAGG-3′; GenBank accession number: 8 
NM_017226.1), rat PAD3 (Forward: 5′-TTGGCTTGTGCTTCCTATGGT-3′, Reverse: 9 
5′-GTAGTGAGGGTGTGAAATAGTCTG-3′; GenBank accession number: 10 
NM_017230.2) and rat PAD4 (Forward: 5′-GCTGGGAAGGATCAGAGCAC-3′, 11 
Reverse: 5′-GGGAGTCTTCGTGCTTAGGG-3′; GenBank accession number: 12 
NM_017227.1). The qPCR reactions were performed in duplicate. A standard curve 13 
was used to calculate expression of the PADs and proFLG normalized to rat GAPDH, 14 
which served as the endogenous control (Forward: 5′-15 
GACATGCCGCCTGGAGAAAC-3′, Reverse: 5′-AGCCCAGGATGCCCTTTAGT-16 
3′; GenBank accession number: NM_017008), and the relative quantity was compared.  17 
 18 
Gel electrophoresis and western blot analysis  19 
The rat oral mucosa was minced and homogenized in lysis buffer containing 8 M 20 
urea, 10 mM EDTA, 1 mM dithiothreitol (DTT), 50 mM Tris-HCl (pH 8.0), and 1% 21 
protease inhibitor cocktail (Sigma). After extraction, the lysates (15 µg) were 22 
centrifuged for 5 min at 1000 × g, and the proteins were resolved on gradient sodium 23 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels (4-20%). For 24 
two-dimensional (2D) gel electrophoresis, the proteins (50–80 µg) were extracted with 25 
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lysis buffer containing 8 M urea, 2 M thiourea, 2% CHAPS, 1% Triton X-100, 2% 1 
Biolyte (pH 4–10; BioRad, Hercules, CA), 10 mg/mL DTT, 1% protease inhibitor 2 
cocktail, and 10 mM Tris-Cl (pH 8.0). Proteins were loaded on agarose gels with a pH 3 
range of 3–10 (A-M310, agarGEL; ATTO Corp., Tokyo, Japan), separated in the first 4 
dimension using non-equilibrium pH gradient electrophoresis (NEpHGE) (20), and 5 
separated on SDS-PAGE gradient gels (4–20%). Then the samples were 6 
electrophoretically transferred to a PVDF membrane (Hybond-P; GE Healthcare, 7 
Wauwatosa, WI). Total protein staining was performed using colloidal gold solution 8 
(ProtoGold; Agar Scientific, Essex, UK). To detect MC proteins, citrulline residues on 9 
the membrane were modified with 2,3-butanedion monoxime and antipyrine by 10 
overnight incubation under acidic conditions (Anti-Citrulline [Modified) Detection Kit, 11 
17-347B; EMD Millipore). For protein detection, membranes were incubated with anti-12 
FLG serum (1:100,000), and anti-MC (1:1000), CCP (1:500), β-actin (1:1000), and K1 13 
(1:100), antibodies followed by incubation with horseradish peroxidase (HRP)-14 
conjugated goat anti-rabbit and anti-mouse IgG antibodies (1:400,000; Jackson 15 
ImmunoResearch, West Grove, PA), and goat anti-human IgG (1:2000, EMD 16 
Millipore). For stripping of immunoblots, membrane was incubated with 62.5 mM Tris 17 
buffer (pH=6.7) containing 100 mM 2-mercaptoethanol and 2% SDS at 37 oC for 15 18 
min. Proteins were visualized using enhanced chemiluminescence (ImmunoStar LD; 19 
Wako Pure Chemical, Osaka, Japan).  20 
 21 
PAD activity 22 
An antibody-based assay for PAD activity (ABAP assay) was performed to measure 23 
PAD activity (21) (MQ17.101-96, ModiQuest Research, Nijmegen, The Netherlands). 24 
Briefly, tissue samples were homogenized in lysis buffer (100 mM NaCl, 10 mM β-25 
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mercaptoethanol, 10% glycerol, 1% protease inhibitor cocktail, 20 mM Tris-HCl pH 1 
7.4). After centrifugation at 4°C, the tissue supernatant (1 µg total protein) or blank 2 
supernatant diluted in citrullination buffer containing different concentrations of 3 
calcium was incubated at 37°C for 75 min in the wells in which arginine-containing 4 
peptides were immobilized. Immobilized peptides containing citrulline were used as a 5 
positive control. PAD activity was assayed using a specific monoclonal mouse antibody 6 
for citrulline, HRP-labeled anti-mouse IgG antibody, and tetramethylbenzidine 7 
substrate, followed by measurement of optical density at 450 nm (OD450) in a 8 
microplate reader (1420 ARVO MX; Perkin Elmer Inc., Waltham, MA). Specific PAD 9 
activity in several tissue types was calculated using a regression line of the relationship 10 
between the measured OD450 values and the known activities (0.012–3 mU) of human 11 
recombinant PAD4 (hPAD4) on a semi-log scale. 12 
 13 
Reconstruction of a rat oral mucosal model using collagen gel matrix culture  14 
Oral mucosa was obtained from the palatal and buccal regions of 7-day-old Wistar 15 
rats. All procedures were conducted based on previous studies on oral mucosa (14, 22, 16 
23). Epithelium and lamina propria were separated from the mucosa after incubation 17 
with dispase. The latter was minced into pieces and cultured in Dulbecco’s Modified 18 
Eagle Medium (DMEM) containing 10% fetal bovine serum (FBS). After fibroblasts 19 
were sprouted from the tissue, the cells were cultured in new medium for 5–6 days, 20 
followed by one round of subculturing. A total of 3 mL type I collagen gel was mixed 21 
with 2 × 106 fibroblast cells, and poured onto a cell culture insert (2.5 cm diameter, 22 
Millicell CM; Millipore) as previously described (14). After digestion of the epithelial 23 
tissue with trypsin, the cells were suspended in MCDB-153 media (Kinousei Peptide 24 
Institute, Yamagata, Japan) and then overlaid on the collagen gel. The culture insert was 25 
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placed in an outer dish containing MCDB-153 + DMEM medium (1:1) supplemented 1 
with additives as previously reported (14), and incubated at 37ºC, 5% CO2. After the 2 
epithelial cells grew to confluency, the cells on the gel surface were cultured at an air–3 
liquid interface (airlift) by removing the medium from the cell culture insert and 4 
replacing the medium in the outer dish with DMEM supplemented with 10% FBS and 5 
growth factors in the presence of Cl-amidine, acefylline or vehicle (0.1% dimethyl 6 
sulfoxide) as a control.  7 
To analyze permeability of the oral mucosal model, 200 µL of 1 M Lucifer yellow 8 
CH dilithium salt solution (Sigma) was added to the surface of the model. After 9 
incubation at 37°C for 10 h, the model was fixed in 4% PFA and embedded in paraffin. 10 
The sections were examined under a fluorescence microscope, and the fluorescence 11 
intensity within the non-cornified epithelial area was quantified using ImageJ software 12 
(NIH). The permeability index was calculated by dividing the intensity by the non-13 
cornified area. 14 
 15 
Statistics 16 
All values are presented as the mean ± standard error of the mean. Statistical 17 
analysis was performed using one-way analysis of variance followed by a post hoc test. 18 
P values less than 0.05 were considered statistically significant. 19 
 20 
Results 21 
Expression and degradation of FLG and proFLG in rat stratified epithelial tissues 22 
We performed histological examination of the skin, palate, and buccal mucosa from 23 
7-day-old rats by H&E staining (Fig. 1A). In the skin, interfollicular keratinocytes were 24 
well flattened within the granular layers, and dot-like staining of the keratohyalin 25 
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granules was observed. In the palate, squamous epithelial cells and fewer granules were 1 
observed. The buccal mucosa possessed thick layers with poor cornification where the 2 
cells exhibited minimal flattening and contained granules.  3 
Initially, we confirmed that positive staining was not observed without using the 4 
primary antibodies and antiserum employed in the present study (data not shown). 5 
Previously, Senshu et al. (19) demonstrated that the anti-FLG antiserum they raised was 6 
capable of detecting rat FLG precursors and breakdown products as well as FLG 7 
monomers. Fluorescence microscopy showed that the same antiserum exhibited intense 8 
immunofluorescence in the lower cornified layer of 7-day-old rat skin (Fig. 1A). The 9 
immunoreactivity faded towards the superficial part of the cornified layer. The presence 10 
of many stained nodules with obscured outlines in the granular layer indicated the 11 
notable presence of proFLG in the keratohyalin granules. In the palate, continuous 12 
staining was barely detected in the mucosal layers, although punctuate staining was 13 
visible throughout the granular layer, suggesting the presence of proFLG. Faint granular 14 
immunoreactivity was observed in the buccal mucosa. Figure 1B shows the quantitative 15 
analysis of FLG and proFLG immunofluorescence from four preparations. The relative 16 
values of the immunoreactive areas were statistically different among the three tissues 17 
in the descending order of skin > palate > buccal mucosa.  18 
Figure 1C shows the immunoblot profiles obtained after probing with anti-FLG 19 
antiserum. The major band located at 48 kDa from skin samples represented the FLG 20 
monomer, as previously identified (19). Additional bands were also noted below 40 21 
kDa, representing the degradation products of FLG. Diffuse signals in the upper part of 22 
the lane probably represent high molecular weight precursors of FLG, such as proFLG 23 
(~400 kDa) and its processing intermediates including FLG dimers. In contrast, the 24 
FLG monomer and its high molecular weight precursor were less intensely stained in 25 
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palate samples, and only a faint proFLG signal was detected in the upper part of the 1 
lane of the buccal mucosa samples.  2 
 3 
Expression and activity of PAD in stratified rat epithelial tissues 4 
To investigate the expression of PAD isozymes in rat skin and oral mucosal tissues, 5 
we performed qPCR and immunoblot experiments. First, representative amplification 6 
of cDNA with specific primers showed that PAD1, 2, 3, and 4 and proFLG were 7 
expressed in the three types of epithelial tissues or whole skin as a control (Fig. 2A). 8 
PCR analysis demonstrated that the mRNA levels of proFLG, a major substrate of the 9 
PADs, were expressed in descending order of skin >> palate > buccal mucosa (Fig. 2B), 10 
consistent with the expression of FLG protein. We used qPCR to examine the mRNA 11 
levels of PAD1, PAD2, PAD3, and PAD4 in the epithelial layers (Fig. 2C). Both PAD2 12 
and PAD4 mRNA was expressed in descending order of skin >> palate = buccal mucosa, 13 
whereas PAD1 mRNA expression was highest in the palate (Fig. 2C). PAD3 mRNA 14 
was present at very low levels in oral tissues relative to the skin. 15 
The ABAP assay was performed in 5 mM calcium-containing deimination buffer. 16 
The specific activity of PAD in the epithelial layers was highest in the skin, next highest 17 
in the palate, and lowest in the buccal mucosa (Fig. 2D). We assayed PAD activity in 18 
different calcium conditions as each PAD isozyme reportedly has distinct calcium 19 
dependency. Interestingly, in the presence of 10 µM calcium, PAD activity was highest 20 
in the palatal mucosa of the three tissues, and mirrored PAD1 mRNA expression. In the 21 
presence of 100 µM calcium, PAD activity was the same in the skin and palate. The 22 
calcium dependency index suggested that PAD activity was considerably dependent on 23 
calcium in the skin, but had small dependence in the oral mucosa, and activity was 24 
likely to be retained in the palate even in the presence of calcium concentrations as low 25 
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as 10 µM. 1 
 2 
Detection of citrullinated proteins in stratified rat epithelial tissues 3 
Figure 3A shows the immunoblot profiles upon probing with the anti-CPP antibody, 4 
which recognizes synthetic CCP originating from the primary structure of FLG. The 5 
major signal had an apparent molecular weight of 50 kDa. Immunoblots probed with 6 
anti-MC antibody, which recognizes citrulline residues after chemical modification, 7 
revealed a major band at 50 kDa and a strong smear signal in the upper region of the 8 
lane. Without the chemical modification, this antibody would not show reactivity. The 9 
intensity of these signals was in the descending order of skin > palate > buccal mucosa. 10 
Although citrullinated FLG and proFLG signals were likely present, other citrullinated 11 
proteins in the upper part of the lane and those at about 50–60 kDa, such as K1, should 12 
also be taken into account.  13 
To discriminate between citrullinated keratins and FLG by protein charge, we 14 
performed 2D gel electrophoresis using NEpHGE in the first dimension and SDS-15 
PAGE in the second dimension (Fig. 3B). Type I and type II keratins were acidic 16 
(isoelectric point [pI] = 4–5) and relatively basic (pI = 6–8), respectively, whereas FLG 17 
was a much more basic protein (pI = 10). The twin protein spots located around 50 kDa 18 
on the most cathodic side of the membrane were immunoreactive to anti-FLG antiserum. 19 
After the blot was stripped, we confirmed that there was no immunodetection of spots 20 
after incubation with the secondary antibody alone (data not shown). This suggests that 21 
no residual traces of bound FLG antibody immunoreacted with the spots. Re-probing 22 
of the blot with anti-CCP antibody revealed that FLG-immunoreactive spots included 23 
anti-CCP reactivity, suggesting that the FLG monomer was partly citrullinated in the 24 
skin (Fig. 3B). Total protein staining revealed multiple spots in the middle and anodic 25 
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side of the membrane, which likely included K1 and K10. Some of the spots (50 and 1 
60 kDa) reacted positively with the anti-CCP antibody. In the palate, a small spot 2 
located around 50 kDa on the most cathodic side of the membrane also reacted with 3 
anti-FLG antiserum, although the signal was rather weak, so CCP immunoreactivity 4 
was not evident (Fig. 3B). 5 
 6 
Co-existence of structural proteins and PAD in the cornified and granular layers 7 
of the skin and palatal mucosa 8 
To determine the tissues where the structural proteins (FLG and K1) and PAD1 9 
associated physically or functionally, we performed immunofluorescence experiments 10 
and viewed the images by confocal microscopy (Fig. 4). Signals for both FLG and K1 11 
overlapped in the lower cornified layer of the skin. Pearson’s colocalization coefficient 12 
was 0.96 in the cornified layer and 0.62 in the granular layer (squares in Fig. 4), 13 
suggesting the probable physical association of these proteins in KIFs. Merged 14 
localization was not observed in the palate or buccal mucosa (coefficients; 0.54 in the 15 
palate and 0.34 in the buccal mucosa). In both the skin and palatal mucosa, we observed 16 
the continuous immunofluorescence of PAD1 in the cornified layer, and a number of 17 
dot-like stains in the granular layer. Intense co-localization of PAD1 and K1 was 18 
detected in the cornified layer of the skin, suggesting that the chemical modification of 19 
K1 and probably FLG occurs in this tissue. However, such co-localization was not 20 
found in the superficial layers of the palatal mucosa. In the buccal mucosa, PAD 21 
localization was not observed. 22 
Next, we immunostained the citrullinated proteins using anti-CCP antibody (Fig. 23 
4) and observed an intense signal in the cornified layer of the skin, but a faint signal in 24 
the palatal and buccal mucosal layers. A considerable part of the K1 signal was merged 25 
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with the CCP signal, indicating that K1 and probably FLG are citrullinated in the 1 
cornified layer of the skin. The continuous MC staining in the cornified layer of skin 2 
was also merged with FLG staining. Scattered staining of MC and proFLG was found 3 
in the granular layer of the palate, some of which overlapped, indicating that proFLG 4 
may be citrullinated in keratohyalin granules (Fig. 4). 5 
 6 
Organotypic culture models of rat palatal mucosa: Involvement of PAD in 7 
modification of FLG 8 
Next, we analyzed the structure of the stratified layers during keratinization using 9 
reconstruction models (8 days after airlifting) derived from epithelial cells and 10 
fibroblasts isolated from the palatal mucosa of 7-day-old rats. As previously reported 11 
(14), the culture models retained their multi-layered epithelial structure with a cornified 12 
layer (Fig. 5A, control). The dot-like distribution of proFLG and diffusible localization 13 
of K1 were found in the granular layers. Similar to the in vivo palate preparation (see 14 
Fig. 4), the scattered staining of proFLG was merged with MC staining in the granular 15 
layer of the organotypic culture model (Fig. 5B, control).  16 
Cl-amidine is a pan-inhibitor of PAD (24). We confirmed that this compound (10 17 
µM) effectively reduced citrullination of histone H3 in the presence of hPAD4 using 18 
anti-MC antibody in immunoblot study (Fig. 5C). Cl-amidine significantly decreased 19 
PAD activity in rat palatal epithelial lysates and recombinant hPAD4 in the ABAP assay. 20 
In the presence of Cl-amidine, the reconstruction model appeared to be tightly overlaid 21 
with the cornified layer and the cells were flattened in the granular layer (Fig. 5A). 22 
Acefylline (100 µM), an activator of PAD1 and PAD3 (25), increased PAD activity of 23 
the rat palatal epithelium in the ABAP assay. The surface structure appeared to be looser 24 
and the cells exhibited minimal flattening (Fig. 5A).  25 
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We examined the effects of Cl-amidine and acefylline on the expression of FLG, 1 
K1, and citrullinated proteins in the reconstruction models. Neither Cl-amidine nor 2 
acefylline changed K1 immunostaining in the granular layer, but nonspecific staining 3 
was occasionally observed in some basal cells. Treatment with Cl-amidine resulted in 4 
continuous FLG staining in the cornified layers as well as granular proFLG staining 5 
(Fig. 5A, B). Interspersed co-localization was found in the confocal images of surface 6 
FLG and K1 immunoreactivity (Fig. 5B). Both continuous and granular FLG staining 7 
was negative to the anti-MC antibody. Acefylline did not cause apparent changes in 8 
FLG immunoreactivity (Fig. 5A). Some fine dots showed co-immunoreactivity with 9 
proFLG and MC (Fig. 5B). Immunoblot analysis showed that Cl-amidine significantly 10 
increased the FLG monomer signal (48 kDa) 2.5-fold, whereas acefylline tended to 11 
decrease the signal (Fig. 6A).  12 
To examine whether PAD activity is involved in the epithelial structure, epithelial 13 
thickness was quantified in the presence or absence of Cl-amidine and acefylline. Cl-14 
amidine significantly decreased epithelial thickness and the relative value of the 15 
cornified layer relative to the entire epithelial layer (Fig. 6B). Acefylline significantly 16 
increased epithelial thickness although relative thickness remained unchanged. Then 17 
we further investigated whether the change in PAD activity altered mucosal 18 
permeability. The fluorescence dye Lucifer yellow was applied to the surface of the 19 
models in the presence or absence of these compounds. The dye was allowed to 20 
penetrate the cornified layer and left to stain below the layer for 10 h. Cl-amidine 21 
significantly inhibited dye permeability whereas acefylline enhanced it (Fig. 6C). 22 
 23 
Discussion 24 
Processing of proFLG has several crucial roles in maintaining epidermal integrity 25 
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such as aligning KIFs, and controlling significant changes in cell shape and epidermal 1 
texture (4). Knockdown of FLG in the reconstructed epidermis or organotypic skin 2 
models by single hairpin RNA and small interference RNA technology was shown to 3 
disrupt the diffusion barrier in a dye penetration assay (26, 27). In flaky tail mice, which 4 
lack normal proFLG, barrier function was impaired (28). FLG-null (Flg-/-) mice 5 
exhibited loss of keratin patterns and deficiency of barrier integrity (29). Transient 6 
overexpression of FLG resulted in collapse of the intermediate filament network (30, 7 
31). Thus, the proFLG system should be distinct among epithelia types to provide 8 
suitable rigidity and permeability to the environment. This study demonstrated the 9 
diffuse localization of FLG in the cornified layer of the skin, but not in the palate or 10 
buccal mucosa of rats, whereas granular localization of proFLG was detected in the rat 11 
skin and palate. The distinct expression of FLG and proFLG in different epithelial types 12 
has also been previously reported in humans. Immunofluorescence with the antibody 13 
against (pro)FLG showed diffuse staining in the cornified layer of the human palate and 14 
scattered dot-like staining in the granular layer of the palate and buccal mucosa, 15 
suggestive of proFLG deposition in keratohyalin granules (15, 16). Immunoblot 16 
analysis showed that both the FLG monomer and proFLG were present in the palate, 17 
whereas only proFLG was found in the buccal mucosa (15). These results suggest some 18 
species-specific differences in FLG and proFLG expression in different parts of the oral 19 
mucosa. 20 
PAD1 is distributed in all living layers of the human epidermis and in granular and 21 
weakly cornified layers of the mouse epidermis (11). Other PAD isozymes may also be 22 
involved in the granular and lower cornified layers, with some redundancy (5, 11). In 23 
this study, the relative expression level of PAD1 was highest in the rat palate, whereas 24 
that of PAD2, PAD3, and PAD4 was highest in the skin, indicative of some tissue-25 
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specific PAD expression. Interestingly, the ABAP assay revealed that maximal PAD 1 
activity in the presence of 5 mM calcium was lower in the palate than in the skin, but 2 
the rank order of PAD activity reversed with decreasing concentrations of calcium, 3 
suggesting that calcium dependency is completely different between the two epithelial 4 
types. Notably, hPAD1 and hPAD3 were fully effective in catalyzing FLG citrullination 5 
at calcium concentrations less than 1.0 mM and 1.5 mM, respectively (8). In contrast, 6 
hPAD2 required more than 2.5 mM calcium to produce maximal activity in 7 
citrullinating FLG (8). Therefore, the high level of PAD1 in the palate allowed FLG 8 
citrullination even under low calcium concentrations. Because a gradient of calcium 9 
concentration has been reported in the epidermis (32), a relationship between 10 
intracellular calcium levels and the specific expression of the PAD isozymes with 11 
distinct calcium dependency in oral mucosa should be clarified in future studies. 12 
FLG and K1 are preferentially citrullinated during the terminal differentiation of 13 
human epidermis (33). PAD1, but not other isozymes, is present in the uppermost 14 
cornified layer in the skin (8) and is responsible for K1 citrullination at this level (7, 15 
10). FLG has been reported to be co-localized with PAD3 as well as PAD1 in the keratin 16 
matrix of lower cornified layer. In the human granular layer, proFLG has been shown 17 
to be co-localized with PAD1 and PAD3 on the granules; only PAD1 but not proFLG 18 
nor PAD3 were detected on the KIFs (8). The present study showed entirely distinct 19 
patterns of co-localization among the epithelial types in rats; FLG and K1 were co-20 
localized with PAD1 in the cornified layers of skin, suggesting that FLG monomer and 21 
PAD may associate with KIFs and create tight bundles. However, neither FLG 22 
monomer nor K1 was co-expressed on the surface of the palate even though PAD1 was 23 
present (Fig. 7). Because of the granular presence of proFLG and PAD1, keratohyalin 24 
granules may be another place for citrullination by PAD1 in the palate, although other 25 
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protein substrates of PAD1, as yet uncharacterized, might be involved.  1 
To determine where citrullinated proteins are localized in these epithelia, we took 2 
two approaches to detect the citrullination of FLG and keratins. It was reported that 3 
synthetic CCP originating from FLG recognized autoantibodies directed toward 4 
citrullinated protein generated in rheumatoid arthritis patients (34). This study used an 5 
anti-CCP antibody raised against cyclic synthetic peptide including citrulline residues 6 
within human FLG. This antibody likely recognized citrullinated FLG in our 7 
immunoblot and immunohistochemistry experiments. Furthermore, detection of the 8 
MC residues revealed the presence of citrullinated (pro)FLG (19). In our western blot 9 
analyses combined with 2D electrophoresis, the anti-CCP antibody was capable of 10 
detecting FLG monomer, whereas the anti-MC antibody likely detected proFLG, its 11 
processing intermediates, and the FLG monomer as well as all citrullinated proteins. 12 
The more intense FLG immunoreactivity in the three epithelial types and additional 13 
immunoreactive spots observed by 2D gel electrophoresis indicated the involvement of 14 
other citrullinated proteins such as K1, K10, and hornerin (35).  15 
Our immunofluorescence studies revealed the overlapping surface distribution of 16 
K1, FLG, and CCP staining, suggesting that chemical modification of K1/FLG likely 17 
take places in the cornified layers of the skin. In the palate and its culture model, clear 18 
dot-like staining was observed in the immunofluorescent images for proFLG and MC, 19 
suggesting that chemical modification of proFLG is likely to be predominantly in 20 
keratohyalin granules, consistent with the previous notion of proFLG citrullination in 21 
keratohyalin granules (36–38). Loss of positive charges in proFLG could affect the 22 
integrity of the oral mucosa, for example, by altering the alignment of KIFs and 23 
changing the cell shape and mucosal texture (Fig. 7). 24 
As mentioned above, the amount and type of PAD isozymes, their substrates, and 25 
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conditions of citrullination reactions were clearly distinct among the three epithelial 1 
types. To understand the precise role of PAD in the structure and function of oral 2 
mucosa, we attempted to make experimental conditions other than PAD activity the 3 
same using a rat 3D mucosal model and two types of compounds that are known to 4 
modify PAD. Cl-amidine inhibits the calcium-bound form of PADs and is the most 5 
widely used pan-PAD inhibitor in numerous disease models (24). As a PAD activator, 6 
xanthine derivative acefylline is useful for the citrullination of FLG by PAD1 and PAD3 7 
(25). The present study revealed that PAD inhibition decreased the epithelium thickness 8 
and Lucifer yellow permeability concomitantly with an increase in expression of the 9 
FLG monomer. The fact that citrullination was lost in granular proFLG staining and 10 
that K1 and FLG monomer were co-expressed suggests that the persistent presence of 11 
FLG monomer may cause keratins to bundle tightly to make the epithelial compact in 12 
the PAD-deficient palate. On the other hand, further activation of PAD by acefylline in 13 
the palatal epithelium decreased expression of the FLG monomer, and increased the 14 
epithelium thickness and dye permeability. These data suggest that FLG citrullination 15 
contributes to the breakdown of (pro)FLG and the intrinsic structure of the oral mucosa 16 
to affect the barrier function. The present study strongly supports the notion that 17 
citrullinated filaggrin is involved in the function and morphology of stratified epithelia 18 
(10). 19 
In conclusion, citrullination is likely to play an important role in maintaining 20 
structure and function of oral mucosa. The results of this study provide new insights 21 
into the complex mechanism underlying the cornification and stratification of 22 
epithelium in the oral mucosa, and paves the way for new pharmacological approaches 23 
directed toward the maintenance of sustainable oral health. 24 
 25 
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Figure Legends 1 
Fig. 1 Histological and immunofluorescence examination of the skin, palate, and buccal 2 
mucosa in 7-day-old rats. A, Hematoxylin and eosin staining (upper) and profilaggrin 3 
(proFLG) immunofluorescence using anti-filaggrin (FLG) antiserum (middle and 4 
lower). The arrowheads indicate keratohyalin granules (upper) and dot-like 5 
immunoreactivity for proFLG (lower). The squares a, b, and c are enlarged in the lower 6 
panels. Purple: DAPI staining. Broken line indicates the basement membrane. Dotted 7 
line indicates the surface of the epithelium. B, Quantitative analysis of relative area of 8 
the proFLG immunofluorescence. **P < 0.01; one-way analysis of variance followed 9 
by the post hoc Dunnett’s test (n = 4). C, A representative image of immunoblot for 10 
proFLG protein. P, I, F, and D denote proFLG (~400 kDa), the processing intermediates 11 
of proFLG, FLG monomers (~48 kDa), and the degradation products of the monomers, 12 
respectively. Expression of β-actin is shown as a loading control. 13 
 14 
Fig. 2 Expression of peptidylarginine deiminase (PAD) and filaggrin in the skin, palate, 15 
and buccal mucosa of rats. A, Typical real-time PCR results obtained using cDNA 16 
derived from three types of epithelial tissues and whole skin with specific primer pairs 17 
for PAD1–4 and GAPDH. B, Typical real-time PCR results and quantitative PCR data 18 
obtained using primer pairs for profilaggrin (proFLG) (n = 4 animals per group). C, 19 
Quantitative real-time PCR measurements of PAD1, PAD2, PAD3, and PAD4 mRNA 20 
are shown (n = 4 animals per group). Expression values were calculated by the relative 21 
standard curve method. *P < 0.05, **P < 0.01, ***P < 0.001; one-way analysis of 22 
variance followed by the post hoc Dunnett’s t-test. D, PAD specific activity was 23 
measured in the presence of 10 µM, 100 µM, and 5 mM Ca2+ (antibody-based assay for 24 
PAD activity assay) using lysate (1 µg) obtained from 3 epithelial types (n = 3–4) (left). 25 
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The ratio of PAD activity in 5 mM Ca2+ to that in 10 µM Ca2+ is shown to clarify the 1 
distinct calcium dependency among the three. *P < 0.05, **P < 0.01, ***P < 0.001; 2 
one-way analysis of variance followed by the post hoc Bonferroni’s t-test. 3 
 4 
Fig. 3 Separation of citrullinated protein in the skin, palate, and buccal mucosa of rats. 5 
A, immunoblot following 4–20% gradient sodium dodecyl sulfate-polyacrylamide gel 6 
electrophoresis (SDS-PAGE) using anti-cyclic citrullinated peptide (CCP) and anti-7 
modified citrulline (MC) protein antibodies. Immunoreactivity of anti-MC antibody 8 
with or without citrulline modification of the skin sample is also shown. Expression of 9 
β-actin is shown as a loading control. B, Two-dimensional profiles of immunoblot using 10 
anti-filaggrin (FLG) antiserum and anti-CPP antibody. The samples were loaded on 11 
agarose gels, separated in the first dimension using NEpHGE, and separated in the 12 
second dimension by SDS-PAGE. FLG: immunodetection of (pro)FLG. CCP: 13 
immunodetection of citrullinated protein. Merged skin and palate: images obtained by 14 
superimposing total protein (colloidal gold) with (pro)FLG (green) and the citrullinated 15 
proteins (red). 16 
 17 
Fig. 4 Immunofluorescence images for expression of (pro)filaggrin [(pro)FLG], 18 
peptidylarginine deiminase (PAD)1, and citrullinated proteins in the skin, palate, and 19 
buccal mucosa of rats under a confocal microscope. For detection of the citrullinated 20 
proteins, anti-cyclic citrullinated peptide (CCP) antibody and anti-modified citrulline 21 
(MC) antibody were used. (G): green. (R): red. Yellow staining denotes the overlapping 22 
signals. Squares are enlarged in the lower panels. Arrowheads indicate the dot-like 23 
immunoreactivity for proFLG and MC. Purple: DAPI staining. Broken line indicates 24 
the basement membrane. Dotted line indicates the surface of the epithelium. 25 
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 1 
Fig. 5 Organotypic reconstruction models using epithelial cells and fibroblasts 2 
dissociated from rat palatal mucosa. The models were cultured in the presence or 3 
absence of a pan- peptidylarginine deiminase (PAD) inhibitor Cl-amidine (10 µM) or 4 
acefylline (100 µM) for 5 days. A, Hematoxylin and eosin (H&E) staining and 5 
immunofluorescence using anti-filaggrin (FLG) antiserum in the reconstruction models. 6 
The squares are enlarged. Arrowheads denote granular presence of profilaggrin 7 
(proFLG). Broken line indicates the basement membrane. B, Confocal images using 8 
anti-FLG antiserum, anti-keratin 1 (K1), and anti-modified citrulline (MC) antibodies 9 
in the reconstruction models. (G): green. (R): red. Yellow staining (arrows) denotes the 10 
overlapping granular signals. Dotted line indicates the surface of the epithelium. C, 11 
Validity of Cl-amidine and acefylline in modulating PAD activity was tested. 12 
Immunoblotting using anti-MC antibody was performed in the presence of recombinant 13 
human PAD4 (hPAD4) and histone H3 as a substrate with or without Cl-amidine. An 14 
antibody-based assay for PAD activity assay to check the validity of Cl-amidine and 15 
acefylline was also performed using hPAD4 and rat palatal epithelial lysate (n = 3). 16 
PAD specific activity was measured in the presence of 5 mM Ca2+ using lysate (1 µg) 17 
obtained from rat palatal epithelium. 18 
 19 
Fig. 6 Quantitative analysis of epithelial structure and expression pattern of filaggrin 20 
(FLG) in the reconstruction models treated for 5 days with or without Cl-amidine (10 21 
µM) or acefylline (100 µM). A, Immunoblot using anti-FLG antiserum (upper). 22 
Quantitative measurement of FLG monomer (48 kDa, closed triangle) is shown (n = 4) 23 
(lower). Expression of β-actin is shown as a loading control. B, Thickness of all 24 
epithelial layers (upper) and relative thickness of the cornified layer with respect to all 25 
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epithelial layers (lower) (n = 6). C, Permeability to lower epithelium with Lucifer 1 
yellow applied onto the surface of the palate models. After 10 h, the models were fixed. 2 
Permeability index was calculated using fluorescence intensity within the noncornified 3 
area (surrounded by broken lines) (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001; one-4 
way analysis of variance followed by post hoc Bonferroni’s t-test. 5 
 6 
Fig. 7 Schematic models of enzymatic breakdown of profilaggrin (proFLG) in rat skin 7 
and palate. ProFLG is stored in keratohyalin granules of the granular layer. ProFLG is 8 
proteolyzed to FLG monomers which associate with keratin intermediate filaments 9 
(KIF) in the cornified layer of the skin. Peptidylarginine deiminase (PAD) including 10 
PAD1 is co-localized in KIF and/or keratohyalin granules, and is likely to citrullinate 11 
FLG or proFLG (denoted as open marks) and to decrease the intermolecular interaction 12 
resulting in proteolytic degradation. PAD3 may be involved in protein citrullination in 13 
skin (8). The pattern of proFLG breakdown in the palate is likely to be distinct from 14 
that in the skin. 15 
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